DEFECTIVE BILE ACID SYNTHESIS IN CHILDHOOD CONSTIPATION
Project Number1R03DK064891-01A1
Contact PI/Project LeaderHOFMANN, ALAN F
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN DIEGO
Description
Abstract Text
DESCRIPTION (provided by applicant):
Constipation in children is a common, vexing problem for the patient, his or her parents, and the pediatric gastroenterologist. Most cases have no discernible organic cause. Evidence indicates that endogenous C24 dihydroxy- bile acids (chenodeoxycholic and/or deoxycholic acid) act as natural cathartics by inducing colonic secretion and colonic propulsion. Our hypothesis is that some cases of childhood constipation are caused by defects in bile acid biosynthesis resulting in a decreased colonic concentration of C24 dihydroxy bile acids. Possible defects include defective hydroxylation of the steroid nucleus (defective sterol 12 hydroxylase (cyp8B1) or defective side chain oxidation (defects in peroxisomal enzymes). To test this hypothesis, fecal samples will be obtained from children with chronic constipation as well as from children without constipation. Samples will be analyzed by electrospray mass spectrometry (ESI-MS) and by gas chromatography mass spectrometry (GC-MS). ESI-MS provides information on side chain biotransformations involved in oxidation of the C8 cholesterol side chain to the C5 side chain present in C24 bile acids. GC-MS provides information on the efficiency of C-12 hydroxylation. Patients with defects in side chain oxidation or C-12-hydroxylation will receive genetic analysis by collaborators. If successful, this project will show that some cases of constipation are caused by defective bile acid biosynthesis.Preliminary results have identified children with increased C27 bile acids suggesting defects in peroxisomal enzymes. Results of this study should lead to clinical trials that test the efficacy of oral primary bile acids for constipation caused by defective bile acid biosynthesis.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
848
DUNS Number
804355790
UEI
UYTTZT6G9DT1
Project Start Date
15-August-2004
Project End Date
31-July-2006
Budget Start Date
15-August-2004
Budget End Date
31-July-2005
Project Funding Information for 2004
Total Funding
$152,000
Direct Costs
$100,000
Indirect Costs
$52,000
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Diabetes and Digestive and Kidney Diseases
$152,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03DK064891-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03DK064891-01A1
Patents
No Patents information available for 1R03DK064891-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03DK064891-01A1
Clinical Studies
No Clinical Studies information available for 1R03DK064891-01A1
News and More
Related News Releases
No news release information available for 1R03DK064891-01A1
History
No Historical information available for 1R03DK064891-01A1
Similar Projects
No Similar Projects information available for 1R03DK064891-01A1